{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Latuda+%28Lurasidone%29", "query": { "intervention": "Latuda (Lurasidone)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 69, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Latuda+%28Lurasidone%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T19:00:54.736Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00806234", "title": "Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psychotic Disorders" ], "interventions": [ { "name": "Aripiprazole or Perphenazine", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "8 Years to 19 Years" }, "enrollment_count": 127, "start_date": "2009-01", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2017-04-25", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 4, "location_summary": "Baltimore, Maryland • Glen Oaks, New York • Chapel Hill, North Carolina", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Glen Oaks", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00806234" }, { "nct_id": "NCT01821378", "title": "Lurasidone Low-Dose - High-Dose Study Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Lurasidone", "type": "DRUG" }, { "name": "Lurasidone 80 mg once daily initially rerandomized either to 80 mg or 160 mg at week 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 412, "start_date": "2013-05", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2016-07-21", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 28, "location_summary": "Little Rock, Arkansas • Cerritos, California • Escondido, California + 22 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01821378" }, { "nct_id": "NCT00549718", "title": "Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Lurasidone HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 489, "start_date": "2007-10", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2014-06-11", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 21, "location_summary": "Little Rock, Arkansas • Cerritos, California • Costa Mesa, California + 18 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Paramount", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00549718" }, { "nct_id": "NCT03402152", "title": "NRX101 Glx Biomarker Validation Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Bipolar Depression", "Suicidal Ideation" ], "interventions": [ { "name": "NRX-101", "type": "DRUG" }, { "name": "Lurasidone HCl", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeuroRx, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 8, "start_date": "2018-11-01", "completion_date": "2021-06-01", "has_results": false, "last_update_posted_date": "2022-08-09", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03402152" }, { "nct_id": "NCT00088621", "title": "A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Lurasidone 80mg tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 61, "start_date": "2004-07", "completion_date": "2005-10", "has_results": true, "last_update_posted_date": "2014-04-17", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Cerritos, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00088621" }, { "nct_id": "NCT01423253", "title": "Major Depressive Disorder With Mixed Features - Extension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Lurasidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 48, "start_date": "2011-09", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2016-04-08", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Escondido, California • Garden Grove, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01423253" }, { "nct_id": "NCT01620060", "title": "Lurasidone Pediatric Pharmacokinetics Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia", "Autism" ], "interventions": [ { "name": "Lurasidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 105, "start_date": "2012-06", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2016-04-08", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 10, "location_summary": "Little Rock, Arkansas • Springdale, Arkansas • Murrieta, California + 7 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Murrieta", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01620060" }, { "nct_id": "NCT03395392", "title": "NRX-101 for Bipolar Depression With Subacute Suicidal Ideation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Bipolar Depression", "Suicidal Ideation and Behavior" ], "interventions": [ { "name": "NRX-101", "type": "DRUG" }, { "name": "Lurasidone HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeuroRx, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 74, "start_date": "2022-05-12", "completion_date": "2024-03-30", "has_results": false, "last_update_posted_date": "2024-05-08", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 14, "location_summary": "Culver City, California • Miami Lakes, Florida • Atlanta, Georgia + 10 more", "locations": [ { "city": "Culver City", "state": "California" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Savannah", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03395392" }, { "nct_id": "NCT00549666", "title": "A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pharmacokinetics" ], "interventions": [ { "name": "Lurasidone 40 mg", "type": "DRUG" }, { "name": "Placebo 40 mg", "type": "DRUG" }, { "name": "Ortho Tri-Cyclen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "18 Years to 40 Years · Female only" }, "enrollment_count": 23, "start_date": "2007-08", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2011-09-14", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00549666" }, { "nct_id": "NCT01911429", "title": "Pediatric Schizophrenia Efficacy and Safety Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Lurasidone 40 mg", "type": "DRUG" }, { "name": "Lurasidone 80 mg", "type": "DRUG" }, { "name": "Placebo 40 or 80 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "13 Years to 17 Years" }, "enrollment_count": 327, "start_date": "2013-08", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2017-04-18", "last_synced_at": "2026-09-27T19:00:54.736Z", "location_count": 36, "location_summary": "Dothan, Alabama • Anaheim, California • Bakersfield, California + 33 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" }, { "city": "Culver City", "state": "California" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01911429" } ] }